Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster dose of Prevenar 13 in children primed with Synflorix or Prevenar 13 in Slovakia
2012-005367-27Phase 3Completed
- Sponsor
- Biovomed
- Start
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by Biovomed. Started Feb 2013; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2012-005367-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005367-27.